SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFM14A - Definitive proxy statement relating to merger or acquisition:
SEC Accession No. 0001193125-21-236673
Filing Date
2021-08-05
Accepted
2021-08-04 21:47:11
Documents
17

Document Format Files

Seq Description Document Type Size
1 DEFM14A d174118ddefm14a.htm DEFM14A 4357026
2 GRAPHIC g174118g01a01.jpg GRAPHIC 237790
3 GRAPHIC g174118g02a02.jpg GRAPHIC 384029
4 GRAPHIC g174118g09z95.jpg GRAPHIC 120066
5 GRAPHIC g174118g18i76.jpg GRAPHIC 156115
6 GRAPHIC g174118g20s37.jpg GRAPHIC 38410
7 GRAPHIC g174118g34a14.jpg GRAPHIC 70011
8 GRAPHIC g174118g34d39.jpg GRAPHIC 110426
9 GRAPHIC g174118g34j26.jpg GRAPHIC 59326
10 GRAPHIC g174118g34n93.jpg GRAPHIC 61276
11 GRAPHIC g174118g47y20.jpg GRAPHIC 63690
12 GRAPHIC g174118g48u05.jpg GRAPHIC 47083
13 GRAPHIC g174118g59p26.jpg GRAPHIC 36929
14 GRAPHIC g174118g66v44.jpg GRAPHIC 55922
15 GRAPHIC g174118g79g23.jpg GRAPHIC 40550
16 GRAPHIC g174118g83r15.jpg GRAPHIC 73035
17 GRAPHIC g174118g99g20.jpg GRAPHIC 97699
  Complete submission text file 0001193125-21-236673.txt   6567421
Mailing Address 17 STATE STREET, 21 FLOOR NEW YORK NY 10004
Business Address 17 STATE STREET, 21 FLOOR NEW YORK NY 10004 646-465-9002
Chardan Healthcare Acquisition 2 Corp. (Filer) CIK: 0001799850 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFM14A | Act: 34 | File No.: 001-39271 | Film No.: 211146017
SIC: 2836 Biological Products, (No Diagnostic Substances)